Biobased factor VIII therapies in hemophilia A patients


Farmacokinetiek en -dynamiek

The landscape of drug development as well as clinical practice has been changing  over the last decennium, with the increasing availability and use of biobased therapies. This research is now focusing on the use and therapeutic drug monitoring of biobased factor VIII therapies in hemophilia A patients.


2018

2022

Utrecht

Anouk Donners

Toine Egberts

Karin Rademaker
Erik van Maarseveen